Effective January 25, 2017, the board of Lantheus Holdings, Inc. appointed Julie H. McHugh to serve as a member of the board. She recently served as Chief Operating Officer of Endo Health Solutions, Inc., where she was responsible for the specialty pharmaceutical and generic drug businesses. Ms. Hugh was appointed as a Class II Director, with an initial term expiring at the company's 2017 annual meeting of stockholders. The board also appointed Ms. McHugh as a member of the Compensation Committee of the Board (the Compensation Committee).